Immune response to SARS-CoV-2 vaccination in relation to peripheral immune cell profiles among patients with multiple sclerosis receiving ocrelizumabSaskia Räuber, David Kremer, Thomas Müntefering et al.|Journal of Neurology Neurosurgery & Psychiatry|2022Cited by 30
Effect of Previous Disease-Modifying Therapy on Treatment Effectiveness for Patients Treated With OcrelizumabSteffen Pfeuffer, Sven G. Meuth, Leoni Rolfes et al.|Neurology Neuroimmunology & Neuroinflammation|2023Cited by 10